论文部分内容阅读
近年来世界药业的资产重组、购并活动十分活跃，世界排名列前的跨国公司大都进行了不同规模的联合、兼并、重组。葛兰素－史克必成、辉瑞－华纳兰博特、赫斯特－罗纳、阿斯特拉－捷利康等超大规模的跨国制药公司在重组中都实现了优势互补，突出了主业，强化了其核心竞争力，在?
In recent years, the world pharmaceutical assets reorganization and mergers and acquisitions are very active, most of the world’s top multinational companies conducted various sizes of mergers, mergers and reorganizations. GSK - Schneider Bicheng, Pfizer - Warner Lambert, Hearst - Rhone, Astra - Jie Likang and other large multinational pharmaceutical companies in the reorganization have achieved the advantages of each other, highlighting the main industry , Strengthened its core competitiveness, in?